Alumis (ALMS) Other Accumulated Expenses (2023 - 2025)
Alumis' (ALMS) quarterly Other Accumulated Expenses came in at $81000.0 in Q4 2025, down 48.73% year-on-year from $158000.0 in Q4 2024, and up 28.57% on a QoQ basis from $63000.0 in Q3 2025.
Alumis (ALMS) Other Accumulated Expenses (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Other Accumulated Expenses data on file, last reported at $81000.0 in Q4 2025.
- On a quarterly basis, Other Accumulated Expenses fell 48.73% year-over-year to $81000.0 in Q4 2025; TTM through Dec 2025 was $81000.0, a 48.73% decrease from a year earlier, with the FY2025 full-year figure at $81000.0, down 48.73% from the prior year.
- Other Accumulated Expenses for Q4 2025 stood at $81000.0, up from $63000.0 in the prior quarter.
- Over the last five years, Other Accumulated Expenses for ALMS reached as high as $550000.0 in Q2 2024 and fell as low as $63000.0 in Q3 2025.
- Historically, Other Accumulated Expenses has averaged $262625.0 across 3 years, with a median of $253000.0 in 2024.
- Across the five-year window, Other Accumulated Expenses tumbled 61.37% in 2024 and declined 18.18% in 2025, its largest moves.
- Year by year, Other Accumulated Expenses stood at $409000.0 in 2023, then tumbled by 61.37% to $158000.0 in 2024, then sank by 48.73% to $81000.0 in 2025.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $81000.0 in Q4 2025, $63000.0 in Q3 2025, and $348000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - |
| 4 | BeOne Medicines | 469.11 Bn | 464.32 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.03 Bn | 115.78 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.37 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.44 Bn | 63.44 Bn | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Alumis | 2.43 Bn | 2.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 81,000.00 |
| Sep 30, 2025 | 63,000.00 |
| Jun 30, 2025 | 348,000.00 |
| Mar 31, 2025 | 415,000.00 |
| Dec 31, 2024 | 158,000.00 |
| Sep 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 550,000.00 |
| Dec 31, 2023 | 409,000.00 |